Orbimed Advisors LLC

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
14-Feb-24 4:02 PM
View: 
Theseus Pharmaceuticals, Inc. (THRX) 14-Feb-24Disposition (change in control)
Duplicate
17,713,600----(100%)
17.71M to 0
31-Jan-24 4:12 PM
View: 
Arrivent Biopharma, Inc. (AVBP) 30-Jan-24Conversion
Duplicate
2,582,880----100%
0 to 2.58M
31-Jan-24 4:12 PM
View: 
Arrivent Biopharma, Inc. (AVBP) 30-Jan-24Purchase
Duplicate
444,444$18.00$7,999,990.0017%
2.58M to 3.03M
26-Jan-24 7:14 PM
View: 
Adicet Bio, Inc. (ACET) 25-Jan-24Private Purchase
Duplicate
3,125,000$2.40$7,500,000.0038%
8.32M to 11.45M
25-Jan-24 4:28 PM
View: 
Edgewise Therapeutics, Inc. (EWTX) 23-Jan-24Private Purchase 454,545$11.00$5,000,000.003%
14.3M to 14.76M
16-Jan-24 4:39 PM
View: 
Nivalis Therapeutics, Inc. (ALPN) 11-Jan-24Exercise (in-the money or at-the-money)
Duplicate
145,251$12.74$1,850,500.006%
2.54M to 2.68M
29-Dec-23 4:18 PM
View: 
Nivalis Therapeutics, Inc. (ALPN) 28-Dec-23Sale 1,364,850$18.35$25,049,000.00(35%)
3.9M to 2.54M
29-Dec-23 4:18 PM
View: 
Nivalis Therapeutics, Inc. (ALPN) 27-Dec-23Private Sale 181,498$19.96$3,622,700.00(4%)
4.08M to 3.9M
20-Dec-23 6:28 PM
View: 
Disc Medicine, Inc. (IRON) 18-Dec-23Option Exercise 1,724$38.00$65,512.00< 1%
1.7M to 1.7M
20-Dec-23 6:28 PM
View: 
Disc Medicine, Inc. (IRON) 18-Dec-23Option Sale 1,724$59.24$102,130.00(< 1%)
1.7M to 1.7M
14-Dec-23 5:44 PM
View: 
Disc Medicine, Inc. (IRON) 14-Dec-23Sale
Duplicate
200$57.73$11,546.00(< 1%)
2.14M to 2.14M
15-Dec-23 6:04 PM
View: 
Disc Medicine, Inc. (IRON) 14-Dec-23Private Sale 433,200$56.75$24,584,100.00(20%)
2.14M to 1.7M
14-Dec-23 5:44 PM
View: 
Disc Medicine, Inc. (IRON) 13-Dec-23Sale
Duplicate
106,700$58.56$6,248,350.00(5%)
2.24M to 2.14M
14-Dec-23 5:44 PM
View: 
Disc Medicine, Inc. (IRON) 12-Dec-23Private Sale
Duplicate
27,300$60.16$1,642,370.00(1%)
2.27M to 2.24M
24-Nov-23 4:38 PM
View: 
Pmv Pharmaceuticals, Inc. (PMVP) 22-Nov-23Sale 87,786$2.23$195,763.00(1%)
6.56M to 6.48M
04-Oct-23 5:36 PM
View: 
Neuropace Inc (NPCE) 03-Oct-23Sale 700$9.02$6,314.00(< 1%)
4.0M to 4.0M
04-Oct-23 5:36 PM
View: 
Neuropace Inc (NPCE) 02-Oct-23Sale 7,614$9.08$69,135.10(< 1%)
4.01M to 4.0M
31-Aug-23 5:26 PM
View: 
Ars Pharmaceuticals, Inc. (SPRY) 29-Aug-23Purchase
Duplicate
500,000$6.20$3,100,000.006%
8.74M to 9.24M
17-Aug-23 4:40 PM
View: 
Galecto, Inc. (GLTO) 15-Aug-23Sale 822,680$0.75$617,010.00(27%)
3.06M to 2.24M
14-Sep-23 9:22 PM
View: 
Ikena Oncology, Inc. (IKNA) 04-Aug-23Grant
Duplicate
153,121----2%
7.78M to 7.93M
02-Aug-23 5:05 PM
View: 
Galecto, Inc. (GLTO) 31-Jul-23Market Sale 209,400$3.00$628,200.00(6%)
3.33M to 3.12M
6%
27-Jul-23 4:28 PM
View: 
Galecto, Inc. (GLTO) 25-Jul-23Market Sale 39,200$2.92$114,464.00(1%)
3.37M to 3.33M
4%
24-Jul-23 4:38 PM
View: 
Turnstone Biologics Corp. (TSBX) 20-Jul-23Conversion 2,682,600----100%
0 to 2.68M
24-Jul-23 4:38 PM
View: 
Turnstone Biologics Corp. (TSBX) 20-Jul-23Purchase 416,666$12.00$4,999,990.0016%
2.68M to 3.1M
19-Jul-23 4:15 PM
View: 
Theseus Pharmaceuticals, Inc. (THRX) 17-Jul-23Private Purchase 479,932$3.05$1,463,790.003%
17.23M to 17.71M
17-Jul-23 4:13 PM
View: 
Galecto, Inc. (GLTO) 13-Jul-23Sale 194,700$2.40$467,280.00(5%)
3.56M to 3.37M
29-Jun-23 4:42 PM
View: 
Passage Bio, Inc. (PASG) 28-Jun-23Purchase 575,195$0.84$483,164.008%
7.46M to 8.03M
29-Jun-23 4:46 PM
View: 
Adicet Bio, Inc. (ACET) 27-Jun-23Private Purchase 875,000$2.09$1,828,750.0012%
7.45M to 8.32M
29-Jun-23 4:42 PM
View: 
Passage Bio, Inc. (PASG) 27-Jun-23Private Purchase 617,382$0.84$518,601.009%
6.84M to 7.46M
24-May-23 5:09 PM
View: 
Prelude Therapeutics Inc (PRLD) 22-May-23Private Purchase
Duplicate
869,565$5.75$5,000,000.009%
9.78M to 10.65M
19-May-23 4:19 PM
View: 
Enliven Therapeutics, Inc. (ELVN) 17-May-23Option Exercise
Duplicate
2,125$4.28$9,095.00< 1%
8.95M to 8.95M
15-May-23 6:07 PM
View: 
Verona Pharma Plc (VRNA) 15-May-23Sale
Duplicate
359,713$20.08$7,222,480.00(9%)
4.14M to 3.78M
15-May-23 6:07 PM
View: 
Verona Pharma Plc (VRNA) 12-May-23Sale
Duplicate
43,200$21.64$934,848.00(1%)
4.18M to 4.14M
15-May-23 6:07 PM
View: 
Verona Pharma Plc (VRNA) 11-May-23Private Sale
Duplicate
80,000$22.26$1,780,800.00(2%)
4.26M to 4.18M
08-May-23 5:22 PM
View: 
Kinnate Biopharma Inc. (KNTE) 05-May-23Purchase
Duplicate
981,023$2.82$2,766,480.0014%
7.03M to 8.01M
08-May-23 5:22 PM
View: 
Kinnate Biopharma Inc. (KNTE) 04-May-23Private Purchase
Duplicate
479,909$2.75$1,319,750.007%
6.55M to 7.03M
02-May-23 10:00 PM
View: 
Kinnate Biopharma Inc. (KNTE) 02-May-23Purchase 338,262$2.67$903,160.005%
6.21M to 6.55M
02-May-23 10:00 PM
View: 
Kinnate Biopharma Inc. (KNTE) 01-May-23Purchase 716,157$2.62$1,876,330.0013%
5.49M to 6.21M
02-May-23 10:00 PM
View: 
Kinnate Biopharma Inc. (KNTE) 28-Apr-23Private Purchase 350,749$2.55$894,410.007%
5.14M to 5.49M
21-Apr-23 5:08 PM
View: 
Tela Bio, Inc. (TELA) 21-Apr-23Sale 27,700$9.41$260,657.00(< 1%)
2.86M to 2.84M
21-Apr-23 5:08 PM
View: 
Tela Bio, Inc. (TELA) 20-Apr-23Sale 28,300$9.43$266,869.00(< 1%)
2.89M to 2.86M
21-Apr-23 5:08 PM
View: 
Tela Bio, Inc. (TELA) 19-Apr-23Sale 136,000$9.30$1,264,800.00(4%)
3.03M to 2.89M
17-Apr-23 5:28 PM
View: 
Galecto, Inc. (GLTO) 17-Apr-23Sale 13,089$1.97$25,785.30(< 1%)
3.58M to 3.56M
17-Apr-23 5:28 PM
View: 
Galecto, Inc. (GLTO) 14-Apr-23Sale 41,446$1.86$77,089.60(1%)
3.62M to 3.58M
17-Apr-23 5:28 PM
View: 
Galecto, Inc. (GLTO) 13-Apr-23Sale 13,946$1.82$25,381.70(< 1%)
3.63M to 3.62M
12-Apr-23 6:44 PM
View: 
Galecto, Inc. (GLTO) 12-Apr-23Sale 2,363$1.81$4,277.03(< 1%)
3.64M to 3.63M
12-Apr-23 6:44 PM
View: 
Galecto, Inc. (GLTO) 11-Apr-23Sale 13,946$1.82$25,381.70(< 1%)
3.65M to 3.64M
12-Apr-23 6:44 PM
View: 
Galecto, Inc. (GLTO) 10-Apr-23Sale 51,228$1.79$91,698.10(1%)
3.74M to 3.69M
07-Apr-23 4:42 PM
View: 
Galecto, Inc. (GLTO) 06-Apr-23Sale 9,665$2.00$19,330.00(< 1%)
3.71M to 3.7M
07-Apr-23 4:42 PM
View: 
Galecto, Inc. (GLTO) 05-Apr-23Sale 92,965$2.18$202,664.00(2%)
3.8M to 3.71M